We serve Chemical Name:2-(1H-benzimidazol-2-yl)-1H-benzimidazole CAS:6965-02-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(1H-benzimidazol-2-yl)-1H-benzimidazole
CAS.NO:6965-02-2
Synonyms:2,2′-Bibenzimidazole;2,2′-bisbenzimidazole;2,2′-Bi-1H-benzimidazole
Molecular Formula:C14H10N4
Molecular Weight:234.25600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:542.8ºC at 760 mmHg
Density:1.41g/cm3
Index of Refraction:1.809
PSA:57.36000
Exact Mass:234.09100
LogP:3.10620
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,2′-Bibenzimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2′-Bi-1H-benzimidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2′-bisbenzimidazole Use and application,2,2′-Bi-1H-benzimidazole technical grade,usp/ep/jp grade.
Related News: The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. 2-(1H-benzimidazol-2-yl)-1H-benzimidazole manufacturer Some of Amanpour’s counterparts also offered well-wishes on Monday. 2-(1H-benzimidazol-2-yl)-1H-benzimidazole supplier The mode of cooperation between domestic API companies and large international companies can lower the export threshold. 2-(1H-benzimidazol-2-yl)-1H-benzimidazole vendor The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. 2-(1H-benzimidazol-2-yl)-1H-benzimidazole factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.
